Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026)
Envista Holdings' (NVST) quarterly Other Accumulated Expenses came in at $577.9 million in Q2 2026, up 3.42% year-on-year from $558.8 million in Q2 2025, and down 7.09% quarter-over-quarter from $622.0 million in Q4 2025.
Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Envista Holdings' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $577.9 million for Q2 2026.
- On a quarterly basis, Other Accumulated Expenses rose 3.42% year-over-year to $577.9 million in Q2 2026; TTM through Apr 2026 was $577.9 million, a 3.42% increase from a year earlier, with the FY2025 full-year figure at $622.0 million, up 12.36% from the prior year.
- Other Accumulated Expenses retreated to $577.9 million in Q2 2026 per NVST's latest filing, from $622.0 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $626.5 million in Q3 2025 and bottomed at $423.6 million in Q1 2023.
- The 5-year median for Other Accumulated Expenses is $539.4 million (2022), against an average of $516.8 million.
- Across the five-year window, Other Accumulated Expenses slipped 21.76% in 2023 and grew 24.83% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $471.4 million in 2022, then declined by 3.33% to $455.7 million in 2023, then climbed by 21.48% to $553.6 million in 2024, then advanced by 12.36% to $622.0 million in 2025, then dropped by 7.09% to $577.9 million in 2026.
- Per Business Quant, the three latest NVST Other Accumulated Expenses figures stand at $577.9 million (Q2 2026), $622.0 million (Q4 2025), and $626.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 577.90 Mn |
| Dec 31, 2025 | 622.00 Mn |
| Sep 26, 2025 | 626.50 Mn |
| Jun 27, 2025 | 586.00 Mn |
| Mar 28, 2025 | 558.80 Mn |
| Dec 31, 2024 | 553.60 Mn |
| Sep 27, 2024 | 541.40 Mn |
| Jun 28, 2024 | 498.80 Mn |
| Mar 29, 2024 | 458.60 Mn |
| Dec 31, 2023 | 455.70 Mn |
| Sep 29, 2023 | 433.70 Mn |
| Jun 30, 2023 | 434.00 Mn |
| Mar 31, 2023 | 423.60 Mn |
| Dec 31, 2022 | 471.40 Mn |
| Sep 30, 2022 | 462.50 Mn |
| Jul 1, 2022 | 539.40 Mn |
| Apr 1, 2022 | 541.40 Mn |
| Dec 31, 2021 | 562.30 Mn |
| Oct 1, 2021 | 509.90 Mn |
| Jul 2, 2021 | 504.80 Mn |